Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The human nephron filter: toward a continuously functioning, implantable artificial nephron system.

Allen R Nissenson1, Claudio Ronco, Gayle Pergamit

  • 1Department of Medicine, Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA 90095, USA.

Blood Purification
|May 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breaking the Barriers to Innovation in Kidney Care: The Time is Now.

Clinical journal of the American Society of Nephrology : CJASN·2022
Same author

Redefining Medication Management in Dialysis: A Kidney Pharmacy Quality Pyramid.

Kidney medicine·2020
Same author

Advancing American Kidney Health: Perspective from DaVita, Inc.

Clinical journal of the American Society of Nephrology : CJASN·2019
Same author

Palliative dialysis: Addressing the need for alternative dialysis delivery modes.

Seminars in dialysis·2019
Same author

The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration.

Journal of the American Society of Nephrology : JASN·2019
Same author

Integrated Care in ESKD: Perspective of a Large Dialysis Organization.

Clinical journal of the American Society of Nephrology : CJASN·2019
Same journal

Peritoneal Glucose Uptake Reduction by Sodium-Glucose Co-Transporter 2 Inhibitors in Clinical Peritoneal Dialysis.

Blood purification·2026
Same journal

With the Generalization of AI and Algorithms, Will We Still Need a Nephrologist in the Dialysis Room?

Blood purification·2026
Same journal

Could serum CA125 aid the clinical assessment of volume status of end-stage kidney disease patients treated by peritoneal dialysis patients?

Blood purification·2026
Same journal

From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis.

Blood purification·2026
Same journal

Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

Blood purification·2026
Same journal

Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

Blood purification·2026
See all related articles

A novel human nephron filter (HNF) using nanotechnology offers a potential breakthrough for end-stage renal disease patients. This implantable artificial kidney mimics native kidney function, improving quality of life and patient outcomes.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Nephrology

Background:

  • End-stage renal disease affects nearly 900,000 patients globally, with numbers projected to double.
  • Current renal replacement therapies have high mortality and morbidity rates.
  • Existing treatments significantly impact patient quality of life.

Purpose of the Study:

  • To develop a continuously functioning, implantable artificial kidney.
  • To create a novel renal replacement therapy using nanotechnology.
  • To improve patient outcomes and quality of life for individuals with kidney disease.

Main Methods:

  • Development of a human nephron filter (HNF) utilizing nanotechnology.
  • The HNF employs a two-membrane system mimicking glomerular and tubular functions.

Related Experiment Videos

  • Computer modeling was used to assess device performance.

    • Main Results:

    • The HNF computer model demonstrated a glomerular filtration rate equivalent of 30 ml/min.
    • This filtration rate is double that of conventional hemodialysis.
    • The device is designed for continuous operation (12 hours/day, 7 days/week).

    Conclusions:

    • The HNF system represents a potential breakthrough in renal replacement therapy.
    • Nanotechnology-based membranes and elimination of dialysate enhance solute removal.
    • The wearable design and improved function promise better patient outcomes and quality of life.